drugset / Trial / NCT03067623

Autologous Platelet-Rich Plasma (PRP) and Endometrial Thickness

NCT03067623

Phase 2 Unknown 200 enrolled University Magna Graecia
NaSingle-groupOpen-labelTreatment

Summary

The goal of this interventional study is to evaluate the increasing in endometrial thickening after the intrauterine infusion of 0,5-1 ml of autologous Platelet-Rich Plasma (PRP) and the implantation rate in women with thin endometrium undergoing Embryo-transfer, in order to propose a novel therapeutic approach for women with an endometrium \< 7 mm unresponsive to standard treatments.

Timeline

Start
2017-02-27
Primary completion
2019-12-31
Completion
2020-02-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 0.5 ml Other
Subject Platelet Rich Plasma Other / unclassified 1 ml Other

Indications